Dr. Hamburg, but in the second paragraph of your letter last December, you talked about, 'Importing non-FDA-approved drugs represents four potential risks.' No one is talking about importing non-FDA-approved drugs.
Dorgan clarifies that the discussion is about FDA-approved drugs, not non-approved ones.
Share & report
More from Byron Dorgan
The Act's passage last year took many people by surprise, not only among the usual Beltway skeptics here in Washington, DC but across Indian Country.
Madam President, I was not going to speak again, but I was prompted to by my colleague from Alabama, a friend and someone for whom I have great respect. The presentation by my colleague from Alabama suggested that President Obama is moving…
It should be front page, headline news on the Washington Post today but it is not because it happens very day, full scale health care rationing.
Other voices in this conversation
